re: Ann: ANW: AusNiCo Secures a 19.99% Releva... Can we agree on the basic framework of facts here.
Taronga has 57.6mill shrs of which YTC owned 23.7% or 13.65mill.
ANW has 144mill shrs on issue and have to issue 288mill to pay for all Taronga shares which adds up to 432mill ANW - of which 68.25mill will eventually represent the full YTC stake. So YTC will have 15.79% of the future ANW.
In addition to the 432mill ANW they have to issue 65.5mill 4c 2015 options(optimistically priced) to buyout the 13.1mill Taronga options.
Are they the basic facts ?
ANW is a thinly traded stock - their cash is only a ~$mill - we can only hope they have some viable plans to translate any latent value in Taronga into the ANW share price. Hard not to see a CR looming in first half 2013.
Can anybody comment on the exact implications of YTC selling ANW 19.99% through the pre-bid agreement, instead of their full 23.7%. I realize going over 20% triggers some takeover provisions - but surely that will happen soon enough anyway. Just not sure of the tactical reason for that - presumably avoiding some disadvantage for ANW.
- Forums
- ASX - By Stock
- Ann: AusNiCo Secures a 19.99% Relevant Interest i
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $1.470M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $1.746K | 596.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 27576164 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 455000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 27351164 | 0.002 |
13 | 32301009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 455000 | 2 |
0.004 | 9947583 | 10 |
0.005 | 1200000 | 2 |
0.006 | 1479327 | 3 |
0.007 | 142855 | 1 |
Last trade - 13.28pm 27/06/2025 (20 minute delay) ? |
Featured News
C7A (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online